Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody

Yaoxue Xuebao

Volumn 41, Issue 1, 2006, Pages 41-46

  Dai, Yao ^a   Liu, Xiu Jun ^a   Zhen, Yong Su ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Immunoconjugate; Monoclonal antibody; Pingyangmycin; Type IV collagenase

Indexed keywords

ANTIBODY CONJUGATE; ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; BLEOMYCIN A5; COLLAGEN TYPE 4; DRUG DERIVATIVE; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; LIVER TUMOR; MOLECULAR WEIGHT; MOUSE; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN TYPE IV; FEMALE; HUMANS; IMMUNOCONJUGATES; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MOLECULAR WEIGHT; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION;

EID: 33644809991     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Li QB, Xu WF. Novel anticancer targets and drug discovery in post genomic age [J]. Curr Med Chem, 2005,5:53-63.
2. Wang FQ, Shang BY, Zhen YS. Antitumor effects of the immunoconjugate composed of lidamycin and monoclonal antibody 3G11 [J]. Acta Pharm Sin, 2003,38:515-519.
3. Liu XJ, Jiang M, Liu XY, et al. Antitumor effects of the conjugates of pingyangmycin linked to monoclonal antibody 3D6 and its Fab' fragment on hepatoma in mice [J]. Chin J Antibiot, 2002,27:496-501.
4. Jiang M, Huang J, Xue YC, et al. Characterization of a rat monoclonal antibody against hepatoma and cytotoxicity of its pingyangmycin conjugate against hepatoma cells [J]. Chin J Microbiol Immunol, 1991,11:230-233.
5. Wang WG, Wang SH, Xue YC, et al. Effect of the conjugate composed of a human monoclonal antibody and pingyangmycin on mammary cancer [J]. Acta Pharm Sin, 1995,30:583-587.
6. Liu XY, Shang BY, Liu XJ, et al. Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody [J]. Natl Med J China, 2001,81:201-204.
7. Zhu JQ, Wang CW, Zhang KH, et al. Experimental studies on the targeting chemotherapy of human gastric cancer with monoclonal antibody conjugated with pingyangmycin [J]. J Pract Oncol, 1997,12:113-115.
8. Li C. Poly (L-glutamic acid)-anticancer drug conjugates [J]. Adv Drug Del Rev, 2002,54:695-713.
9. Dai Y, Jia B, Wang F, et al. Immunoscintigraphy of anti-type IV collagenase monoclonal antibody in nude mice bearing human lung cancer xenograft [J]. Chin J Cancer, 2003,22:1243-1248.
10. Hamblett KJ, Senter PD, Chace DF, et al. Effects of loading on the antitumor activity of a monoclonal antibody drug conjugate [J]. Clin Cancer Res, 2004,10:7063-7070.
11. Manabe Y, Tsubota T, Haruta Y, et al. Production of a monoclonal antibody-bleomycin conjugate utilizing dextran T-40 and the antigen-targeting cytotoxicity of the conjugate [J]. Biochem Biophys Res Commun, 1983,115:1009-1014.
12. Wang JP, Yang CZ. Studies of two conjugates of monoclonal antibody ( HIM 6 ) and cytosine arabinoside [J]. Acta Acad Med Sin, 1993,15:286-290.
13. Vega J, Ke S, Fan Z, et al. Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly ( L-glutamic acid ) through a polyethylene glycol spacer [J]. Pharm Res, 2003,20:826-832.
14. Liu XY, Zhen YS. Antitumor effects of monoclonal antibody Fab' fragment-containing immunoconjugates [J]. Chin Med Sci J, 2002,17:1-6.